Thromboangiitis obliterans (Buerger disease) in a female mild smoker treated with spinal cord stimulation

American Journal of the Medical Sciences

Volumn 327, Issue 6, 2004, Pages 365-368

  Manfredini, Roberto ^a   Boari, Benedetta ^a   Gallerani, Massimo ^a   La Cecilia, Olga ^a   Salmi, Raffaella ^b   De Toma, Damiana ^a   Galeotti, Roberto ^a   Ragazzi, Riccardo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b S ANNA HOSPITAL   (Italy)

Author keywords

Spinal cord stimulator; Thromboangiitis obliterans; Vascular diseases

Indexed keywords

PROSTAVASIN; VENLAFAXINE;

ADULT; AGE; ANGIOGRAPHY; ARTICLE; BUERGER DISEASE; CASE REPORT; CLINICAL FEATURE; CYANOSIS; DEPRESSION; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; ITALY; LEG ULCER; MEDICAL INSTRUMENTATION; PHYSICAL EXAMINATION; SMOKING; SPINAL CORD STIMULATION; SYMPTOM;

EID: 2942631610     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200406000-00014     Document Type: Article

References (42)

1. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343:864-69.
2. Makita S, Nakamura M, Murakami H, et al. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996;94(suppl 2):II211-15.
3. Adar R, Papa MZ, Halpern Z, et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983;308:1113-16.
4. Halacheva K, Gulubova MV, Manolova I, et al. Expression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliterans. Acta Histochem 2002;104:177-84.
5. Shionoya S. Buerger's disease: pathology, diagnosis and treatment. Nagoya, Japan: The University of Nagoya Press, 1990.
6. Shionoya S. Buerger's disease (thromboangiitis obliterans). In: Rutherford RB, editor. Vascular surgery. Philadelphia: WB Saunders; 1989. p. 207-17.
7. Mautner GC, Mautner SL, Lin F, et al. Amounts of coronary arterial luminal narrowing and composition of the material causing the narrowing in Buerger's disease. Am J Cardiol 1993;71:486-90.
8. Hoppe B, Lu JT, Thisthewaite P, et al. Beyond peripheral arteries in Buerger's disease: angiographic considerations in thromboangiitis obliterans. Catheter Cardiovasc Interv 2002;57:363-6.
9. Kobayashi M, Kurose K, Kobata T, et al. Ischemic intestinal involvement in a patient with Buerger disease: case report and literature review. J Vasc Surg 2003;38:170-74.
10. Physicians' Desk Reference, 52th ed. Montvale, NJ: Medical Economics Company; 1998. pp. 3037-41.
11. Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990;82(suppl IV):3-8.
12. Sasaki S, Sakuma M, Kunihara T, et al. Current trends in thromboangiitis obliterans (Buerger's disease) in women. Am J Surg 1999;177:316-20.
13. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg 1996;11:335-9.
14. Mills JL, Porter JM. Buerger's disease: a review and update. Semin Vasc Surg 1993;6:14-23.
15. Joyce JW. Buerger's disease (thromboangiitis obliterans). Rheum Dis Clin North Am 1990;116:463-70.
16. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischemia of thromboangiitis obliterans: the TAO Study. Lancet 1990;335:555-57.
17. Matsushita M, Kuzuya A, Kobayashi M, et al. Buerger's disease in a 19-year-old woman. J Vasc Surg 2003;38:175-79.
18. Saha K, Chabra N, Gulati SM. Treatment of patients with thromboangiitis obliterans with cyclophosphamide. Angiology 2001;52:399-407.
19. Isner JM, Baumgartner J, Rauh G, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998;28:964-75.
20. Shionoya S, Ban I, Nakata Y, et al. Diagnosis, pathology and treatment of Buerger's disease. Surgery 1974;75:695-700.
21. Largiader J, Schneider E, Brunner V. Arterial reconstruction in Buerger's disease. VASA 1986;15:174-9.
22. Dilege S, Aksoy M, Kayabali M, et al. Vascular reconstruction in Buerger's disease: is it feasible? Surg Today 2002;32:1042-7.
23. Shindo S, Kubota K, Kojima A, et al. Staged vascular reconstruction along with repeatedly performed angiography to prevent ischemic limb loss with Buerger's disease: report of a case. Surg Today 2001;31:754-58.
24. Cook AW, Oyger A, Baggenstos P, et al. Vascular disease of the extremities: electrical stimulation of spinal cord and posterior roots. N Y State J Med 1976;76:366-8.
25. Robaina FJ, Dominguez M, Diaz M, et al. Spinal cord stimulation for relief of chronic pain in vasospastic disorders of the upper limbs. Neurosurgery 1989;24:63-7.
26. Horsch S, Claeys L. Epidural spinal cord stimulation in the treatment of severe peripheral arterial occlusive disease. Ann Vasc Surg 1994;8:468-74.
27. Augustinsson LE, Linderoth B, Mannheimer C, et al. Spinal cord stimulation in cardiovascular disease. Neurosurg Clin North Am 1995;6:157-65.
28. Ghajar AW, Miles JB. The differential effect of the level of spinal cord stimulation on patients with advanced peripheral vascular disease in the lower limbs. Br J Neurosurg 1998;12:402-8.
29. Claeys LG, Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Angiology 1996;15:344-49.
30. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger disease). J Vasc Surg 1999;29:928-35.
31. Pace AV, Saratzis N, Karokis D, et al. Spinal cord stimulation in Buerger's disease. Ann Rheum Dis 2002;61:1114.
32. Chierichetti F, Mambrini S, Bagliani A, et al. Treatment of Buerger's disease with electrical spinal cord stimulation: review of three cases. Angiology 2002;53:341-47.
33. Milles JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg 1991;5:570-72.
34. Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurements in patients with Buerger's disease-effects of active and passive smoking on the disease process. J Vasc Surg 1991;14:53-8.
35. Narkiewicz K, Van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998;98:528-34.
36. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-4.
37. Chalon S, Moreno H Jr, Benowitz NL, et al. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 2000;67:391-97.
38. Roncon-Albuquerque R, Serrao P, Vale-Pereira R, et al. Plasma catecholamines in Buerger's disease: effects of cigarette smoking and surgical sympathectomy. Eur J Vasc Endovas Surg 2002;24:338-43.
39. Koch A, Hoffmann K, Steck W, et al. Acute cardiovascular reactions after cigarette smoking. Atherosclerosis 1980;35:67-75.
40. Haas M, Kubler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 1997;10:657-65.
41. Grassi G, Serravalle G, Calhoun DA, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-53.
42. Marano G, Ramirez A, Mori I, et al. Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats. Cardiovasc Res 1999;42:201-5.